Donald Trump joked in his last call with Sir Keir Starmer about coyotes needing weight-loss drugs after becoming fat feasting on the remains of birds killed by flying into wind turbines.

Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug spending. But thus far, the data don’t show this.

GLP-1 drugs such as Ozempic and Wegovy are driving down grocery spending, according to a new study from Cornell’s SC Johnson College of Business and consumer data firm Numerator.